CSR Program: City Cancer Challenge | Takeda Pharmaceuticals
Empowering ten global cities to deliver quality and equitable cancer care
Engaging city stakeholders from a diverse range of sectors in the design, planning and implementation of cancer care solutions
The Program
Partner: City Cancer Challenge
Budget: 1 billion yen
Term: 5 years
Launch: 2019
Area: Global
Visit the City Cancer Challenge website
The program will ensure that patients have access to the high-quality cancer care they need and deserve without being exposed to hardship. These efforts will result in stronger health systems while catalyzing investment in cancer and non-communicable diseases (NCDs), which, in turn, will help drive progress towards the global target of reducing premature deaths from NCDs, including cancer.
Have more questions?
Contact us if you'd like more information about our Global CSR Program.